EvoNext Holdings SA publishes half-year report 2025

As regards the half-year 2025 financial report,

(i) during 1H 2025,

• The operating expenses incurred resulted in a loss of CHF 0.361 million;
• An award rendered in a legal proceeding led to a positive compensation of approx. CHF 0.09 million to recoup legal and court fees;
• As communicated before, under the earn-out agreement with Danstar Ferment AG, the agreed sales floor for the second earn-out period (January – June 2025) of CHF 10.29 million was not reached. As a result, no earn-out payment can be expected for 1H 2025.

(ii) on 30 June 2025,

• EvoNext Holdings SA had a cash balance of CHF 6.3 million and short-term receivables of CHF 0.8 million, mainly consisting of CHF 0.6 million in an escrow account which will be released depending on the outcome of a legal case that was transferred as part of the sale of Evolva AG to Danstar Ferment AG;
• Accrued and other current and non-current liabilities of CHF 0.8 million include a reserve taken for the above-mentioned legal case in the amount of CHF 0.6 million;
• The equity balance stands at CHF 6.2 million.

Since the last AGM, at which the shareholders resolved the continuation of M&A activities, the Board of Directors (“Board”) of EvoNext Holdings SA has been exploring potential market opportunities in the area of public mergers and acquisitions, in particular so-called "reverse takeovers”. In this process, the Board is evaluating candidates in order to identify a target for a potential transaction that would create the most value for the company’s shareholders.

Following the expiration of the offer period for GZO AG on 4 July 2025, the Board is currently evaluating other opportunities.

Documentation The half-year 2025 report is available under this link. Contact EvoNext Holdings SA investors@evonextholdings.com  

Disclaimer This announcement is not an offer of securities into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered, pledged, sold, delivered or otherwise transferred, directly or indirectly, in the United States, except pursuant to an exemption from, or transaction not subject to, the registration requirements of the Securities Act. No public offering of securities is being made in the United States. Further, the securities referred to herein have not been and will not be registered under the applicable securities laws of Canada, Australia or Japan or under the applicable securities laws of any other jurisdiction where to do so might constitute a violation of such laws.              This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.